DK3870574T3 - Aminopyridin/pyrazinderivater som ctps1-inhibitorer - Google Patents
Aminopyridin/pyrazinderivater som ctps1-inhibitorer Download PDFInfo
- Publication number
- DK3870574T3 DK3870574T3 DK19789997.4T DK19789997T DK3870574T3 DK 3870574 T3 DK3870574 T3 DK 3870574T3 DK 19789997 T DK19789997 T DK 19789997T DK 3870574 T3 DK3870574 T3 DK 3870574T3
- Authority
- DK
- Denmark
- Prior art keywords
- aminopyridine
- pyrazine derivatives
- ctps1 inhibitors
- ctps1
- inhibitors
- Prior art date
Links
- 102100039866 CTP synthase 1 Human genes 0.000 title 1
- 101001101919 Homo sapiens CTP synthase 1 Proteins 0.000 title 1
- KYQCOXFCLRTKLS-UHFFFAOYSA-N Pyrazine Chemical class C1=CN=CC=N1 KYQCOXFCLRTKLS-UHFFFAOYSA-N 0.000 title 1
- 150000003927 aminopyridines Chemical class 0.000 title 1
- 239000003112 inhibitor Substances 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- General Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Plural Heterocyclic Compounds (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Pyridine Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP18202136 | 2018-10-23 | ||
| PCT/EP2018/086617 WO2019179652A1 (en) | 2018-03-23 | 2018-12-21 | Aminopyrimidine derivatives as ctps1 inhibitors |
| PCT/EP2019/057320 WO2019180244A1 (en) | 2018-03-23 | 2019-03-22 | Aminopyrimidine derivatives as ctps1 inhibitors |
| PCT/EP2019/078848 WO2020083975A1 (en) | 2018-10-23 | 2019-10-23 | Aminopyrimidine/pyrazine derivatives as ctps1 inhibitors |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK3870574T3 true DK3870574T3 (da) | 2023-04-11 |
Family
ID=63965420
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK19789997.4T DK3870574T3 (da) | 2018-10-23 | 2019-10-23 | Aminopyridin/pyrazinderivater som ctps1-inhibitorer |
Country Status (26)
| Country | Link |
|---|---|
| US (3) | US11987573B2 (da) |
| EP (1) | EP3870574B1 (da) |
| JP (1) | JP7308263B2 (da) |
| CN (1) | CN112839938B (da) |
| AU (1) | AU2019367191B2 (da) |
| CA (1) | CA3115568C (da) |
| CR (1) | CR20210265A (da) |
| DK (1) | DK3870574T3 (da) |
| EA (1) | EA202191104A1 (da) |
| ES (1) | ES2941981T3 (da) |
| FI (1) | FI3870574T3 (da) |
| HR (1) | HRP20230328T1 (da) |
| HU (1) | HUE061652T2 (da) |
| IL (1) | IL282386B2 (da) |
| LT (1) | LT3870574T (da) |
| MX (1) | MX2021004659A (da) |
| MY (1) | MY203303A (da) |
| NZ (1) | NZ774355A (da) |
| PL (1) | PL3870574T3 (da) |
| PT (1) | PT3870574T (da) |
| RS (1) | RS64081B1 (da) |
| SG (1) | SG11202103823PA (da) |
| SI (1) | SI3870574T1 (da) |
| SM (1) | SMT202300090T1 (da) |
| WO (1) | WO2020083975A1 (da) |
| ZA (1) | ZA202101788B (da) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2019106146A1 (en) | 2017-11-30 | 2019-06-06 | Step Pharma S.A.S. | Compounds |
| EP3717459B1 (en) | 2017-11-30 | 2026-01-21 | Step Pharma S.A.S. | Compounds |
| WO2020245665A1 (en) | 2019-06-04 | 2020-12-10 | Step Pharma S.A.S. | N-(4-(5-chloropyridin-3-yl)phenyl)-2-(2-(cyclopropanesulfonamido)pyrimidin-4-yl) butanamide derivatives and related compounds as human ctps1 inhibitors for the treatment of proliferative diseases |
| IL288508B2 (en) | 2019-06-04 | 2026-02-01 | Step Pharma S A S | History of n-(5-(6-ethoxypyrazin-2-yl)pyridin-2-yl)-4-(2-(methylsulfonamido)pyrimidin-4-yl)tetrahydro-h2-pyran-4-carboxamide and related compounds as human CTPS1 inhibitors for the treatment of proliferative diseases |
| US20230020663A1 (en) | 2019-09-20 | 2023-01-19 | Step Pharma S.A.S. | Sulfonamide inhibitors as ctps1 inhibitors |
| WO2021053402A2 (en) | 2019-09-20 | 2021-03-25 | Step Pharma S.A.S. | Compounds |
| WO2023166077A1 (en) | 2022-03-01 | 2023-09-07 | Step Pharma S.A.S. | Combination of a ctps1 inhibitor and a atr inhibitor in cancer therapy |
| WO2023166080A1 (en) | 2022-03-01 | 2023-09-07 | Step Pharma S.A.S. | Combination treatments comprising a ctps1 inhibitor and a wee1 inhibitor |
| CA3244038A1 (en) | 2022-03-01 | 2023-09-07 | Step Pharma S.A.S. | COMBINATION OF CTPS1 AND BCL-2 INHIBITORS FOR CANCER TREATMENT |
| WO2023166078A1 (en) | 2022-03-01 | 2023-09-07 | Step Pharma S.A.S. | Combination treatments comprising a ctps1 inhibitor and a chek1 inhibitor |
| WO2024133730A1 (en) | 2022-12-21 | 2024-06-27 | Step Pharma S.A.S. | Ctps1 inhibitors for use in the treatment of ctps2 deficient cancer |
| WO2024133721A1 (en) | 2022-12-21 | 2024-06-27 | Step Pharma S.A.S. | Combinations of ctps1 inhibitor with iap inhibitor for use in the treatment of cancer |
| CN118359588A (zh) * | 2023-01-19 | 2024-07-19 | 杭州英创医药科技有限公司 | 作为ctps1抑制剂的化合物 |
| WO2026027753A1 (en) * | 2024-08-02 | 2026-02-05 | Step Pharma S.A.S. | Ctps1 inhibitors for the treatment of myeloproliferative neoplasms |
| WO2026119228A1 (zh) * | 2024-12-05 | 2026-06-11 | 浙江海正药业股份有限公司 | 磺酰胺类衍生物及其制备方法和用途 |
Family Cites Families (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1575803A (en) | 1976-03-09 | 1980-10-01 | Fujisawa Pharmaceutical Co | 3,7 disubstituted 3 cephem 4 carboxylic acid compounds andprocesses for the preparation thereof |
| GB1555007A (en) | 1976-05-25 | 1979-11-07 | Fujisawa Pharmaceutical Co | Intermediates in the preparation of substituted cepham carboxylic acid derivatives and the preparation thereof |
| NZ523882A (en) | 2000-08-21 | 2004-11-26 | Pacific Corp | Novel thiourea derivatives and the pharmaceutical compositions containing the same |
| US7091201B2 (en) | 2000-09-25 | 2006-08-15 | Actelion Pharmaceuticals Ltd. | Arylalkane-sulfonamides having endothelin-antagonist activity |
| US20030158218A1 (en) | 2001-12-21 | 2003-08-21 | Nantermet Philippe G. | Thrombin inhibitors |
| ES2325836T3 (es) | 2004-07-26 | 2009-09-21 | Merck Serono Sa | Derivados de la n.hidroxiamida y uso de los mismos. |
| EP1659113A1 (en) * | 2004-11-08 | 2006-05-24 | Evotec AG | Inhibitors of 11beta-hydroxy steroid dehydrogenase type 1 (11beta-HSD1) |
| AR063706A1 (es) | 2006-09-11 | 2009-02-11 | Cgi Pharmaceuticals Inc | Determinadas amidas sustituidas, el uso de las mismas para el tratamiento de enfermedades mediadas por la inhibicion de la actividad de btk y composiciones farmaceuticas que las comprenden. |
| JP2011506445A (ja) * | 2007-12-13 | 2011-03-03 | アムジエン・インコーポレーテツド | γ−セクレターゼ調節剤 |
| KR101097312B1 (ko) | 2009-08-10 | 2011-12-23 | 삼성모바일디스플레이주식회사 | 유기 발광 소자 |
| US9359345B2 (en) | 2012-12-13 | 2016-06-07 | Hoffmann-La Roche Inc. | Thiazole derivatives as inhibitors of Bruton's tyrosine kinase |
| JP2016028795A (ja) | 2013-03-28 | 2016-03-03 | 国立研究開発法人科学技術振興機構 | 触媒金属ナノ粒子含有複合体及びその利用 |
| JP2016523818A (ja) * | 2013-04-18 | 2016-08-12 | アンスティチュ ナショナル ドゥ ラ サンテ エ ドゥ ラ ルシェルシュ メディカル | それを必要とする被験体におけるｔ細胞増殖を阻害するための方法及び医薬組成物（ｃｔｐｓ１阻害剤、例えばノルロイシン） |
| WO2014186435A2 (en) * | 2013-05-14 | 2014-11-20 | University Of Georgia Research Foundation, Inc. | Compositions and methods for reducing neointima formation |
| GB201322333D0 (en) | 2013-12-17 | 2014-01-29 | Agency Science Tech & Res | WNT pathway modulators |
| CN104262071A (zh) | 2014-10-16 | 2015-01-07 | 中国科学院山西煤炭化学研究所 | 一种联苯类化合物的光催化合成方法 |
| EP3717459B1 (en) | 2017-11-30 | 2026-01-21 | Step Pharma S.A.S. | Compounds |
| WO2019106146A1 (en) | 2017-11-30 | 2019-06-06 | Step Pharma S.A.S. | Compounds |
| AU2018413791B2 (en) | 2018-03-23 | 2023-05-18 | Step Pharma S.A.S. | Aminopyrimidine derivatives as CTPS1 inhibitors |
| US20230192673A1 (en) * | 2018-06-04 | 2023-06-22 | Step Pharma S.A.S. | Compounds |
| EP4232425A4 (en) | 2020-10-23 | 2024-07-24 | Nimbus Clotho, Inc. | Ctps1 inhibitors and uses thereof |
-
2019
- 2019-10-23 PL PL19789997.4T patent/PL3870574T3/pl unknown
- 2019-10-23 PT PT197899974T patent/PT3870574T/pt unknown
- 2019-10-23 SG SG11202103823PA patent/SG11202103823PA/en unknown
- 2019-10-23 EA EA202191104A patent/EA202191104A1/ru unknown
- 2019-10-23 CR CR20210265A patent/CR20210265A/es unknown
- 2019-10-23 AU AU2019367191A patent/AU2019367191B2/en active Active
- 2019-10-23 HU HUE19789997A patent/HUE061652T2/hu unknown
- 2019-10-23 LT LTEPPCT/EP2019/078848T patent/LT3870574T/lt unknown
- 2019-10-23 RS RS20230239A patent/RS64081B1/sr unknown
- 2019-10-23 CA CA3115568A patent/CA3115568C/en active Active
- 2019-10-23 JP JP2021522085A patent/JP7308263B2/ja active Active
- 2019-10-23 CN CN201980063914.3A patent/CN112839938B/zh active Active
- 2019-10-23 SI SI201930504T patent/SI3870574T1/sl unknown
- 2019-10-23 SM SM20230090T patent/SMT202300090T1/it unknown
- 2019-10-23 MY MYPI2021002215A patent/MY203303A/en unknown
- 2019-10-23 HR HRP20230328TT patent/HRP20230328T1/hr unknown
- 2019-10-23 IL IL282386A patent/IL282386B2/en unknown
- 2019-10-23 DK DK19789997.4T patent/DK3870574T3/da active
- 2019-10-23 FI FIEP19789997.4T patent/FI3870574T3/fi active
- 2019-10-23 MX MX2021004659A patent/MX2021004659A/es unknown
- 2019-10-23 NZ NZ774355A patent/NZ774355A/en unknown
- 2019-10-23 EP EP19789997.4A patent/EP3870574B1/en active Active
- 2019-10-23 US US17/287,137 patent/US11987573B2/en active Active
- 2019-10-23 ES ES19789997T patent/ES2941981T3/es active Active
- 2019-10-23 WO PCT/EP2019/078848 patent/WO2020083975A1/en not_active Ceased
-
2021
- 2021-03-17 ZA ZA2021/01788A patent/ZA202101788B/en unknown
-
2024
- 2024-04-16 US US18/636,731 patent/US12371419B2/en active Active
-
2025
- 2025-05-23 US US19/217,739 patent/US20250282756A1/en active Pending
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK3768674T3 (da) | Aminopyrimidinderivater som ctps1-hæmmere | |
| DK3784664T3 (da) | 2-amino-pyridin- eller 2-amino-pyrimidinderivater som cyclinafhængige kinasehæmmere | |
| DK3464271T3 (da) | Pyrazolderivater som plasma-kallikreininhibitorer | |
| DK3442980T3 (da) | Heterocykliske forbindelser som ret-kinase-hæmmere | |
| DK3728252T3 (da) | 4-azaindolforbindelser | |
| DK3684767T3 (da) | Heterocykliske forbindelser som pad-inhibitorer | |
| DK3704120T3 (da) | Heterocykliske forbindelser som prmt5-inhibitorer | |
| DK3324977T3 (da) | Benzodiazepinderivater som rsv-inhibitorer | |
| DK3533787T3 (da) | Pyridonforbindelse som C-MET-hæmmer | |
| DK3356345T3 (da) | Heteroaryl-derivater som sepiapterin-reduktase-inhibitorer | |
| PL3870574T3 (pl) | Pochodne aminopirymidyny/pirazyny jako inhibitory CTPS1 | |
| DK3371190T3 (da) | Heterocykliske forbindelser som pi3k-gamma-inhibitorer | |
| DK3328849T5 (da) | 1,1,1-trifluor-3-hydroxypropan-2-yl-carbamat-derivater og 1,1,1-trifluor-4-hydroxybutan-2-yl-carbamat-derivater som magl-inhibitorer | |
| DK3313832T3 (da) | 3-tetrazolyl-benzen-1,2-disulfonamidderivater som metallo-beta- lactamase-hæmmere | |
| LT3464272T (lt) | Nauji heterocikliniai dariniai, naudingi kaip shp2 inhibitoriai | |
| DK3302448T3 (da) | Erstattede heterocyclylafledninger som cdk-inhibitore | |
| DK3529241T3 (da) | Pireridinderivater som inhibitorer af ubiquitin-specifik protease 7 | |
| DK3322706T3 (da) | Substituerede pyrazolo[1,5-a]pyridin-forbindelser som ret-kinaseinhibitorer | |
| DK3227297T3 (da) | 4,6-substitueret-pyrazolo[1,5-a]pyraziner som janus kinase-inhibitorer | |
| DK3271349T3 (da) | Benzimidazolederivater som bromodomain-inhibitorer | |
| DK3313838T3 (da) | Polycykliske amidderivater som cdk9-inhibitorer | |
| DK3582780T3 (da) | Aminopyrimidinforbindelser, der er anvendelige som SSAO-inhibitorer | |
| DK3762368T3 (da) | Aminopyrazindiolforbindelser som pi3k-y-inhibitorer | |
| DK3544981T3 (da) | Benzodiazoliumforbindelser som enac-inhibitorer | |
| DK3638680T3 (da) | Heteroaromatiske forbindelser som vanininhibitorer |